Adjuvant therapy for colon and rectal cancer: NIH consensus development conference
- 31 December 1990
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (6) , 753-755
- https://doi.org/10.1016/0277-5379(90)90136-h
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990
- Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic.Journal of Clinical Oncology, 1989
- Adjuvant therapy of poor prognosis colon cancer with levamisole: Results of an EORTC double-blind randomized clinical trialBritish Journal of Surgery, 1989
- Adjuvant Therapy of Colorectal CancerPublished by American Medical Association (AMA) ,1988
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI Journal of the National Cancer Institute, 1988
- Five year results of a randomized trial of adjuvant 5-fluorouracil and levamisole in colorectal cancerBritish Journal of Surgery, 1987
- Survival after Postoperative Combination Treatment of Rectal CancerNew England Journal of Medicine, 1986
- A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancerBritish Journal of Surgery, 1985